osimertinib
astrazeneca
['osimertinib']
so 43 % on placebo arm got osimertinib on progression. are we happy with this number ? looks less than expected ? #asco23 
Oncology care , to give or not to give chemo , data analysis , oncology pharamocovigilance , enthusiastic critic, twitts are not twists